Dolby Laboratories (DLB) to Release Earnings on Wednesday

Dolby Laboratories (NYSE:DLBGet Free Report) is anticipated to post its quarterly earnings results after the market closes on Wednesday, January 29th. Analysts expect Dolby Laboratories to post earnings of $1.07 per share and revenue of $346,145.33 billion for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Dolby Laboratories Price Performance

DLB stock opened at $81.15 on Tuesday. The stock has a market capitalization of $7.75 billion, a PE ratio of 29.95 and a beta of 0.98. The company has a 50 day moving average price of $78.98 and a 200 day moving average price of $75.61. Dolby Laboratories has a fifty-two week low of $66.35 and a fifty-two week high of $85.30.

Dolby Laboratories Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 10th. Shareholders of record on Tuesday, December 3rd were given a dividend of $0.33 per share. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.30. The ex-dividend date was Tuesday, December 3rd. This represents a $1.32 annualized dividend and a dividend yield of 1.63%. Dolby Laboratories’s payout ratio is presently 48.71%.

Insider Buying and Selling at Dolby Laboratories

In other news, Director Peter C. Gotcher sold 6,079 shares of the company’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $78.96, for a total transaction of $479,997.84. Following the completion of the sale, the director now directly owns 37,593 shares in the company, valued at approximately $2,968,343.28. This represents a 13.92 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP John D. Couling sold 50,000 shares of the stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $80.04, for a total transaction of $4,002,000.00. Following the sale, the senior vice president now owns 106,806 shares in the company, valued at $8,548,752.24. The trade was a 31.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 135,917 shares of company stock worth $10,877,739 over the last 90 days. Company insiders own 38.39% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on DLB. Barrington Research reaffirmed an “outperform” rating and set a $100.00 price objective on shares of Dolby Laboratories in a research note on Monday. StockNews.com raised Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, December 4th. Finally, Rosenblatt Securities reiterated a “buy” rating and issued a $100.00 price target on shares of Dolby Laboratories in a report on Thursday, January 23rd.

Read Our Latest Report on Dolby Laboratories

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Read More

Earnings History for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.